Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'designer drugs' OR with Authors including 'designer drugs' OR with Abstract including 'designer drugs' OR with Keywords including 'designer drugs'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Ziporyn T A growing industry and menace: makeshift laboratory's designer drugs JAMA 1986
Beck J, Morgan PA Designer drug confusion: a focus on MDMA J Drug Educ 1986
Climko RP, Roehrich H, Sw... Ecstacy: a review of MDMA and MDA Int J Psychiatry Med 1986
Stone DM, Stahl DC, Hanso... The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... Eur J Pharmacol 1986
Gibb JW, Stone DM, Stahl ... The effects of amphetamine-like designer drugs on monoaminergic system... NIDA Res Monogr 1987
Bost RO 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivat... J Forensic Sci 1988
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Callahan PM, Appel JB Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... J Pharmacol Exp Ther 1988
Stanford MW Designer drugs: Medical aspects and clinical management Alcoholism Treatment... 1988
Schechter MD Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... Pharmacol Biochem Be... 1989
Beebe DK, Walley E Update on street drugs in Mississippi J Miss State Med Ass... 1989
Gold LH, Geyer MA, Koob G... Neurochemical mechanisms involved in behavioral effects of amphetamine... NIDA Res Monogr 1989
Gibb JW, Stone DM, Johnso... Role of dopamine in the neurotoxicity induced by amphetamines and rela... NIDA Res Monogr 1989
Leikin JB, Krantz AJ, Zel... Clinical features and management of intoxication due to hallucinogenic... Med Toxicol Adverse ... 1989
De Souza EB, Battaglia G,... Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... Ann N Y Acad Sci 1990
Kosten TR Neurobiology of abused drugs. Opioids and stimulants J Nerv Ment Dis 1990
Glennon RA Phenylalkylamine stimulants, hallucinogens, and designer drugs NIDA Res Monogr 1991
Ruttenber AJ Stalking the elusive designer drugs: Techniques for monitoring new pro... Journal of Addictive... 1991
Glennon RA Discriminative Stimulus Properties of Hallucinogens and Related Design... NIDA Res Mon 1991
Preston A Pointing out the Risk Nursing Times 1992
Sternbach GL, Varon J 'Designer drugs'. Recognizing and managing their toxic effects Postgrad Med 1992
Thurman EM, Pedersen MJ, ... Distinguishing sympathomimetic amines from amphetamine and methampheta... J Anal Toxicol 1992
Emerson TS, Cisek JE Methcathinone: a Russian designer amphetamine infiltrates the rural mi... Ann Emerg Med 1993
Bronson ME, Jiang W, Clar... Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken Brain Res Bull 1994
House RV, Thomas PT, Bhar... Selective modulation of immune function resulting from in vitro exposu... Toxicology 1995
Bronson ME, Wages TD, Bed... Morphine, MDMA, MDA, and nexus produce a conditioned place preference ... Exp Clin Psychopharm... 1996
Maurer HH On the metabolism and the toxicological analysis of methylenedioxyphen... Ther Drug Monit 1996
Ensslin HK, Kovar KA, Mau... Toxicological detection of the designer drug 3,4-methylenedioxyethylam... J Chromatogr B Biome... 1996
Schwartz RH, Miller NS MDMA (ecstasy) and the rave: a review Pediatrics 1997
Glennon RA, Young R, Duka... Initial characterization of PMMA as a discriminative stimulus Pharmacol Biochem Be... 1997
Kua EH Designer Drugs--the Ecstasy and the Agony Singapore Med J 1997
Tsatsakis AM, Michalodimi... MDEA related death in Crete: a case report and literature review Vet Hum Toxicol 1997
Dal Cason TA The characterization of some 3,4-methylenedioxycathinone MDCATH homolo... Forensic Science Int... 1997
Keller T, Miki A, Regensc... Detection of designer drugs in human hair by ion mobility spectrometry... Forensic Sci Int 1998
Byard RW, Gilbert J, Jame... Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the... Am J Forensic Med Pa... 1998
Plessinger MA Prenatal exposure to amphetamines. Risks and adverse outcomes in pregn... Obstet Gynecol Clin ... 1998
Young R, Glennon RA Discriminative stimulus properties of (-)ephedrine Pharmacol Biochem Be... 1998
Wollina U, Kammler HJ, He... Ecstasy pimples - a new facial dermatosis Dermatology 1998
Schwab M, Seyringer E, Br... Fatal MDMA intoxication Lancet 1999
Ramseier A, Caslavska J, ... Stereoselective screening for and confirmation of urinary enantiomers ... Electrophoresis 1999
Rochester JA, Kirchner JT Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, ... J Am Board Fam Pract 1999
Appel JB, West WB, Roland... Increasing the selectivity of drug discrimination procedures Pharmacol Biochem Be... 1999
Young R, Dukat M, Malmusi... Stimulus properties of PMMA: effect of optical isomers and conformatio... Pharmacol Biochem Be... 1999
Glennon RA Arylalkylamine drugs of abuse: an overview of drug discrimination stud... Pharmacol Biochem Be... 1999
Kreth KP,Kovar KA, Schwab... Identification of the Human Cytochromes P450 Involved in the Oxidative... Biochem Pharmacol 2000
Maurer HH, Bickeboeller-F... Toxicokinetics and analytical toxicology of amphetamine-derived design... Toxicol Lett 2000
Bogusz MJ, Kruger KD, Mai... Analysis of underivatized amphetamines and related phenethylamines wit... J Anal Toxicol 2000
Christophersen AS Amphetamine designer drugs - an overview and epidemiology Toxicol Lett 2000
Morland J Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental e... Toxicol Lett 2000
Ramseier A, Siethoff C, C... Confirmation testing of amphetamines and designer drugs in human urine... Electrophoresis 2000
Clauwaert KM, Van Bocxlae... Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... Clin Chem 2000
Gomez-Balaguer M, Pena H,... Syndrome of Inappropriate Antidiuretic Hormone Secretion and 'Designer... Journal of Pediatric... 2000
Pepin G, Cheze M, Billaul... New hallucinogenic in Europe: Ayahuasca or the Vine of the Spirit Journal of Forensic ... 2000
Borth S, Hänsel W, Rösner... Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their re... Forensic Sci Int 2000
Clauwaert KM, Van Bocxlae... Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... Clin Chem 2000
Anderson C Water intake probed in death Boulder Daily Camera 2001
Zhao H, Brenneisen R, Sch... Profiles of urine samples taken from Ecstasy users at Rave parties: an... J Anal Toxicol 2001
De Letter EA, Coopman VA,... One fatal and seven non-fatal cases of 4-methylthioamphetamine 4-MTA i... Int J Legal Med 2001
de Boer D, Bosman IJ, Hid... Piperazine-like compounds: a new group of designer drugs-of-abuse on t... Forensic Sci Int 2001
Clauwaert KM, Van Bocxlae... Stability study of the designer drugs 'MDA, MDMA and MDEA' in water, s... Forensic Sci Int 2001
Kraemer T, Maurer HH Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... Ther Drug Monit 2002
von Sydow K, Lieb R, Pfis... Use, abuse and dependence of ecstasy and related drugs in adolescents ... Drug and Alcohol Dep... 2002
Glennon RA, Young R, Rang... Further characterization of the stimulus properties of 5,6,7,8- tetrah... Pharmacol Biochem Be... 2002
Pellegrini M, Rosati F, P... Rapid screening method for determination of Ecstasy and amphetamines i... J Chromatogr B Analy... 2002
Wax PM Just a Click Away: Recreational Drug Web Sites on the Internet Pediatrics 2002
Meyer A, Mayerhofer A, Ko... Enantioselective metabolism of the designer drugs 3,4-methylenedioxyme... Neurosci Lett 2002
Simonsen KW, Kaa E, Niels... Narcotics at street level in Denmark. A prospective investigation from... Forensic Sci Int 2003
De Letter EA, Espeel MF, ... Immunohistochemical demonstration of the amphetamine derivatives 3,4-m... Int J Legal Med 2003
Peters FT, Schaefer S, St... Screening for and validated quantification of amphetamines and of amph... J Mass Spectrom 2003
Dams R, De Letter EA, Mor... Fatality due to combined use of the designer drugs MDMA and PMA: a dis... J Anal Toxicol 2003
Turner C, Russell A, Brow... Prevalence of illicit drug use in young Australian women, patterns of ... Addiction 2003
Carvalho M, Milhazes N, R... Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopami... Arch Toxicol 2003
Maurer HH, Kraemer T, Spr... Chemistry, pharmacology, toxicology, and hepatic metabolism of designe... Ther Drug Monit 2004
de la Torre R, Farre; M, ... Clinical pharmacokinetics of amfetamine [amphetamine] and related subs... Clin Pharmacokinet 2004
Boatto G, Nieddu M, Carta... Determination of amphetamine-derived designer drugs in human urine by ... J Chromatogr B Analy... 2005
Fantegrossi WE, Winger G,... Reinforcing and discriminative stimulus effects of 1-benzylpiperazine ... Drug Alcohol Depend 2005
Staack RF, Maurer HH Metabolism of designer drugs of abuse Curr Drug Metab 2005
Casteele SR, Bouche MP, V... LC-MS/MS in the elucidation of an isomer of the recreational drug meth... J Sep Sci 2005
Balíková M Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose Forensic Sci Int 2005
Schifano F, Deluca P, Ago... New trends in the cyber and street market of recreational drugs? The c... J Psychopharmacol 2005
Schifano F, Deluca P, Ago... New trends in the cyber and street market of recreational drugs? The c... J Psychopharmacol 2005
Bossong MG, Van Dijk JP, ... Methylone and mCPP, two new drugs of abuse? Addict Biol 2005
Ewald AH, Fritschi G, Bor... Designer drugs 2,5-dimethoxy-4-bromo-amphetamine DOB and 2,5-dimethoxy... J Mass Spectrom 2006
Theobald DS, Maurer HH Identification of monoamine oxidase and cytochrome P450 isoenzymes inv... Biochem Pharmacol 2007
Itokawa M, Iwata K, Takah... Acute confusional state after designer tryptamine abuse Psychiatry Clin Neur... 2007
Pichini S, Pujadas M, Mar... Liquid chromatography-atmospheric pressure ionization electrospray mas... J Pharm Biomed Anal 2008
Uchiyama N, Kikura-Hanaji... [Analysis of designer drugs detected in the products purchased in fisc... Yakugaku Zasshi 2008
Nakagawa Y, Suzuki T, Tay... Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and ... Arch Toxicol 2009
Westphal F, Junge T, Girr... Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-... Forensic Sci Int 2009
Auwärter V, Dresen S, Wei... 'Spice' and other herbal blends: harmless incense or cannabinoid desig... Journal of Mass Spec... 2009
Mustata C, Torrens M, Par... [Spice drugs: cannabinoids as a new designer drugs] Adicciones 2009
Zaitsu K, Katagi M, Kamat... Determination of the metabolites of the new designer drugs bk-MBDB and... Forensic Sci Int 2009
Lindigkeit R, Boehme A, E... Spice: a never ending story? Forensic Sci Int 2009
Drees JC, Stone JA, Wu AH Morbidity involving the hallucinogenic designer amines MDA and 2C-I J Forensic Sci 2009
Uchiyama N, Miyazawa N, K... [Analysis of newly distributed designer drugs detected in the products... Yakugaku Zasshi 2010
Uchiyama N, Kikura-Hanaji... Chemical analysis of synthetic cannabinoids as designer drugs in herba... Forensic Sci Int 2010
Meyer MR, Wilhelm J, Pete... Beta-keto amphetamines: studies on the metabolism of the designer drug... Anal Bioanal Chem 2010
Lindigkeit R, Böhme A, Ei... Synthese, Charakterisierung und Analyse von JWH-018-StrukturanalogenSy...   2010
Wohlfarth A, Weinmann W Bioanalysis of new designer drugs   2010
Meyer MR, Maurer HH Metabolism of designer drugs of abuse: an updated review Curr Drug Metab 2010

Page 1 of 2   /   154 Entries Returned
2 next